Academic Journals Database
Disseminating quality controlled scientific knowledge

ClinicoEconomics and Outcomes Research

ISSN: 1178--6981
Publisher: Dove Press


ADD TO MY LIST
 
C-QUALITY: cost and quality-of-life pharmacoeconomic analysis of antidepressants used in major depressive disorder in the regional Italian settings of Veneto and Sardinia

Author(s): Mencacci C | Aguglia E | Biggio G | Cappellari L | Di Sciascio G | Fagiolini A | Maina G | Tortorella A | Katz P | Ripellino C
Volume: 2013
Issue: default
Year: 2013
Challenges in measuring and valuing productivity costs, and their relevance in mood disorders

Author(s): Lensberg BR | Drummond MF | Danchenko N | Despiégel N | François C
Volume: 2013
Issue: default
Year: 2013
A systematic review of the effectiveness of taxes on nonalcoholic beverages and high-in-fat foods as a means to prevent obesity trends

Author(s): Maniadakis N | Kapaki V | Damianidi L | Kourlaba G
Volume: 2013
Issue: default
Year: 2013
Outcomes associated with conventional versus lipid-based formulations of amphotericin B in propensity-matched groups

Author(s): Campbell RS | Chaudhari P | Hays HD | Taylor RJ | Nathanson BH | Bozzette SA | Horn DL
Volume: 2013
Issue: default
Year: 2013
Budget impact analysis of conversion from cyclosporine to sirolimus as immunosuppressive medication in renal transplantation therapy

Author(s): Foroutan N | Rasekh HR | Salamzadeh J | Jamshidi HR | Nafar M
Volume: 2013
Issue: default
Year: 2013
Economic evaluation of initial antiretroviral therapy for HIV-infected patients: an update of Italian guidelines

Author(s): Colombo GL | Matteo SD | Antinori A | Medaglia M | Murachelli S | Rizzardini G
Volume: 2013
Issue: default
Year: 2013
Using observational data to inform the design of a prospective effectiveness study for a novel insulin delivery device

Author(s): Grabner M | Chen Y | Nguyen M | Abbott SD | Quimbo R
Volume: 2013
Issue: default
Year: 2013
Cost of noninfectious comorbidities in patients with HIV

Author(s): Guaraldi G | Zona S | Menozzi M | Carli F | Bagni P | Berti A | Rossi E | Orlando G | Zoboli G | Palella F
Volume: 2013
Issue: default
Year: 2013
Long-term cost-effectiveness of atypical antipsychotics in the treatment of adults with schizophrenia in the US

Author(s): O'Day K | Rajagopalan K | Meyer K | Pikalov A | Loebel A
Volume: 2013
Issue: default
Year: 2013
Cost and clinical consequences of smoking cessation in outpatients after cardiovascular disease: a retrospective cohort study

Author(s): Sicras-Mainar A | Díaz-Cerezo S | Sanz de Burgoa V | Navarro-Artieda R
Volume: 2013
Issue: default
Year: 2013
The personal, societal, and economic burden of schizophrenia in the People's Republic of China: implications for antipsychotic therapy

Author(s): Montgomery W | Liu L | Stensl | MD | Xue HB | Treuer T | Ascher-Svanum H
Volume: 2013
Issue: default
Year: 2013
Impact of scribes on patient interaction, productivity, and revenue in a cardiology clinic: a prospective study

Author(s): Bank AJ | Obetz C | Konrardy A | Khan A | Pillai KM | McKinley BJ | Gage RM | Turnbull MA | Kenney WO
Volume: 2013
Issue: default
Year: 2013
Resource use and costs of exenatide bid or insulin in clinical practice: the European CHOICE study

Author(s): Kiiskinen U | Matthaei S | Reaney M | Mathieu C | Östenson C-G | Krarup T | Theodorakis M | Kiljański J | Salaun-Martin C | Sapin H | Guerci B
Volume: 2013
Issue: default
Year: 2013
Retrospective claims analysis of best supportive care costs and survival in a US metastatic renal cell population

Author(s): Henk HJ | Chen C | Benedict A | Sullivan J | Teitelbaum A
Volume: 2013
Issue: default
Year: 2013
Cost-effectiveness of zofenopril in patients with left ventricular systolic dysfunction after acute myocardial infarction: a post hoc analysis of SMILE-4

Author(s): Borghi C | Ambrosioni E | Omboni S | Cicero AFG | Bacchelli S | Degli Esposti D | Novo S | Vinereanu D | Ambrosio G | Reggiardo G | Zava D
Volume: 2013
Issue: default
Year: 2013
Cost-effectiveness of bazedoxifene versus raloxifene in the treatment of postmenopausal women in Spain

Author(s): Darbà J | Pérez-Álvarez N | Kaskens L | Holgado-Pérez S | Racketa J | Rejas J
Volume: 2013
Issue: default
Year: 2013
A cost-of-illness study of spina bifida in Italy

Author(s): Colombo GL | Di Matteo S | Vinci M | Gatti C | Pascali MP | De Gennaro M | Macrellino E | Mosiello G | Redaelli T | Schioppa F | Dieci C
Volume: 2013
Issue: default
Year: 2013
Changes in quality of care and costs induced by implementation of a diabetes program in a social security entity of Argentina

Author(s): González L | Elgart JF | Calvo H | Gagliardino JJ
Volume: 2013
Issue: default
Year: 2013
Cost–utility analysis for platinum-sensitive recurrent ovarian cancer therapy in South Korea: results of the polyethylene glycolated liposomal doxorubicin/carboplatin sequencing model

Author(s): Lee HY | Yang BM | Hong JM | Lee TJ | Kim BG | Kim JW | Kim YT | Kim YM | Kang S
Volume: 2013
Issue: default
Year: 2013
The costs of traumatic brain injury: a literature review

Author(s): Humphreys I | Wood RL | Phillips CJ | Macey S
Volume: 2013
Issue: default
Year: 2013
Estimating the long-term effects of in vitro fertilization in Greece: an analysis based on a lifetime-investment model

Author(s): Fragoulakis V | Maniadakis N
Volume: 2013
Issue: default
Year: 2013
The clinical and economic burden of chronic obstructive pulmonary disease in the USA

Author(s): Guarascio AJ | Ray SM | Finch CK | Self TH
Volume: 2013
Issue: default
Year: 2013
Medical technology as a key driver of rising health expenditure: disentangling the relationship

Author(s): Sorenson C | Drummond M | Bhuiyan Khan B
Volume: 2013
Issue: default
Year: 2013
Antiretroviral treatment switch strategies for lowering the costs of antiretroviral therapy in subjects with suppressed HIV-1 viremia in Spain

Author(s): Llibre JM | Cardona G | Santos JR | Andreu A | Estrada JO | Ara J | Bonafont X | Clotet B
Volume: 2013
Issue: default
Year: 2013
Annual cost of hospitalization, inpatient rehabilitation, and sick leave for head and neck cancers in Germany

Author(s): Klussmann JP | Schädlich PK | Chen X | Rémy V
Volume: 2013
Issue: default
Year: 2013
Glycemic control and diabetes-related health care costs in type 2 diabetes; retrospective analysis based on clinical and administrative databases

Author(s): Degli Esposti L | Saragoni S | Buda S | Sturani A | Degli Esposti E
Volume: 2013
Issue: default
Year: 2013
Homozygous familial hypercholesterolemia (HoFH) in Germany: an epidemiological survey

Author(s): Walzer S | Travers K | Rieder S | Erazo-Fischer E | Matusiewicz D
Volume: 2013
Issue: default
Year: 2013
Clinical and economic outcomes among hospitalized patients with acute coronary syndrome: an analysis of a national representative Medicare population

Author(s): Chen SY | Crivera C | Stokes M | Boulanger L | Schein J
Volume: 2013
Issue: default
Year: 2013
Health-resource use and costs associated with fibromyalgia in France, Germany, and the United States

Author(s): Knight T | Schaefer C | Chandran A | Zlateva G | Winkelmann A | Perrot S
Volume: 2013
Issue: default
Year: 2013
Comparison of health care resource utilization and costs among patients with GERD on once-daily or twice-daily proton pump inhibitor therapy

Author(s): Mody R | Eisenberg D | Hou L | Kamat S | Singer J | Gerson LB
Volume: 2013
Issue: default
Year: 2013
Update on the management of cirrhosis – focus on cost-effective preventative strategies

Author(s): Neff GW | Kemmer N | Duncan C | Alsina A
Volume: 2013
Issue: default
Year: 2013
Update on the treatment of non-small-cell lung cancer: focus on the cost-effectiveness of new agents

Author(s): Vergnenègre A | Borget I | Chouaid C
Volume: 2013
Issue: default
Year: 2013
Improving the economic and humanistic outcomes for diabetic patients: making a case for employer-sponsored medication therapy management

Author(s): Pinto SL | Kumar J | Partha G | Bechtol RA
Volume: 2013
Issue: default
Year: 2013
An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) versus conventional paclitaxel for metastatic breast cancer patients: the COSTANza study

Author(s): Lazzaro C | Bordonaro R | Cognetti F | Fabi A | De Placido S | Arpino G | Marchetti P | Botticelli A | Pronzato P | Martelli E
Volume: 2013
Issue: default
Year: 2013
Follow-up analysis of federal process of care data reported from three acute care hospitals in rural Appalachia

Author(s): Sills ES | Chiriac L | Vaughan D | Jones CA | Salem SA
Volume: 2013
Issue: default
Year: 2013
Do different clinical evidence bases lead to discordant health-technology assessment decisions? An in-depth case series across three jurisdictions

Author(s): Spinner DS | Birt J | Walter JW | Bowman L | Mauskopf J | Drummond MF | Copley-Merriman C
Volume: 2013
Issue: default
Year: 2013
Antiretroviral therapy in HIV-infected patients: a proposal to assess the economic value of the single-tablet regimen

Author(s): Colombo GL | Di Matteo S | Maggiolo F
Volume: 2013
Issue: default
Year: 2013
Cost-effectiveness evaluation of escitalopram in major depressive disorder in Italy

Author(s): Mencacci C | Di Sciascio G | Katz P | Ripellino C
Volume: 2013
Issue: default
Year: 2013
Medical costs and utilization in patients with depression treated with adjunctive atypical antipsychotic therapy

Author(s): Nadkarni A | Kalsekar I | You M | Forbes R | Hebden T
Volume: 2013
Issue: default
Year: 2013
Estimating the willingness to pay for a quality-adjusted life year in Thailand: does the context of health gain matter?

Author(s): Thavorncharoensap M | Teerawattananon Y | Natanant S | Kulpeng W | Yothasamut J | Werayingyong P
Volume: 2013
Issue: default
Year: 2013
Cost-effectiveness of dronedarone and standard of care compared with standard of care alone: US results of an ATHENA lifetime model

Author(s): Reynolds MR | Nilsson J | Åkerborg Ö | Jhaveri M | Lindgren P
Volume: 2013
Issue: default
Year: 2013
Epidemiology of falls and osteoporotic fractures: a systematic review

Author(s): Morrison A | Fan T | Sen SS | Weisenfluh L
Volume: 2013
Issue: default
Year: 2012
Increase in direct diabetes-related costs and resource use in the 6 months following initiation of insulin in patients with type 2 diabetes in five European countries: data from the INSTIGATE study

Author(s): Jones S | Castell C | Goday A | Smith HT | Nicolay C | Simpson A | Salaun-Martin C
Volume: 2012
Issue: default
Year: 2012
Cost and appropriateness of treating asthma with fixed-combination drugs in local health care units in Italy

Author(s): Ruggeri I | Bragato D | Colombo GL | Valla E | Di Matteo S
Volume: 2012
Issue: default
Year: 2012
Budget impact analysis of boceprevir and telaprevir for the treatment of hepatitis C genotype 1 infection

Author(s): Thorlund K | Druyts E | El Khoury AC | Mills EJ
Volume: 2012
Issue: default
Year: 2012
Economic analysis of Heart and Stroke Foundation of Ontario's Hypertension Management Initiative

Author(s): de Oliveira C | Wijeysundera HC | Tobe SW | Moy Lum-Kwong M | Von Sychowski S | Wang X | Tu JV | Krahn MD
Volume: 2012
Issue: default
Year: 2012
The impact of initial statin treatment decisions on cardiovascular outcomes in clinical care settings: estimates using the Archimedes Model

Author(s): van Herick A | Schuetz CA | Alperin P | Bullano MF | Balu S | Gandhi S
Volume: 2012
Issue: default
Year: 2012
Cost-effectiveness of candesartan versus losartan in the primary preventive treatment of hypertension

Author(s): Granström O | Levin LA | Henriksson M
Volume: 2012
Issue: default
Year: 2012
Impact of dry eye on work productivity

Author(s): Yamada M | Mizuno Y | Shigeyasu C
Volume: 2012
Issue: default
Year: 2012
Cost-effectiveness analysis of intranasal live attenuated vaccine (LAIV) versus injectable inactivated influenza vaccine (TIV) for Canadian children and adolescents

Author(s): Tarride JE | Burke N | Von Keyserlingk C | O'Reilly D | Xie F | Goeree R
Volume: 2012
Issue: default
Year: 2012
Maintenance erlotinib in advanced nonsmall cell lung cancer: cost-effectiveness in EGFR wild-type across Europe

Author(s): Walleser S | Ray J | Bischoff H | Vergnenègre A | Rosery H | Chouaid C | Heigener D | de Castro Carpeño J | Tiseo M | Walzer S
Volume: 2012
Issue: default
Year: 2012
Calcipotriol and betamethasone dipropionate in the treatment of mild-to-moderate psoriasis: a cost-effectiveness analysis of the ointment versus gel formulation

Author(s): Colombo GL | Di Matteo S | Bruno G | Girolomoni G | Vena GA
Volume: 2012
Issue: default
Year: 2012
Budget impact analysis of two immunotherapy products for treatment of grass pollen-induced allergic rhinoconjunctivitis

Author(s): Rønborg SM | Svendsen UG | Micheelsen JS | Ytte L | Andreasen JN | Ehlers L
Volume: 2012
Issue: default
Year: 2012
Cost comparison of second-line treatment options for late stage non-small-cell lung cancer: cost analysis for Italy

Author(s): Schwander B | Ravera S | Giuliani G | Nuijten M | Walzer S
Volume: 2012
Issue: default
Year: 2012
Cost of human immunodeficiency virus infection in Italy, 2007–2009: effective and expensive, are the new drugs worthwhile?

Author(s): Rizzardini G | Restelli U | Bonfanti P | Porazzi E | Ricci E | Foglia E | Carenzi L | Croce D
Volume: 2012
Issue: default
Year: 2012
New strategies for lowering the costs of antiretroviral treatment and care for people with HIV/AIDS in the United Kingdom

Author(s): Gazzard B | Moecklinghoff C | Hill A
Volume: 2012
Issue: default
Year: 2012
Economic evaluation of alternative assisted reproduction techniques in management of infertility in Greece

Author(s): Fragoulakis V | Kourlaba G | Tarlatzis B | Mastrominas M | Maniadakis N
Volume: 2012
Issue: default
Year: 2012
State of health economic evaluation research in Saudi Arabia: a review

Author(s): Al-Aqeel SA
Volume: 2012
Issue: default
Year: 2012
Pregabalin versus SSRIs and SNRIs in benzodiazepine-refractory outpatients with generalized anxiety disorder: a post hoc cost-effectiveness analysis in usual medical practice in Spain

Author(s): De Salas-Cansado M | Olivares JM | Álvarez E | Carrasco JL | Barrueta A | Rejas J
Volume: 2012
Issue: default
Year: 2012
Forecast model for the evaluation of economic resources employed in the health care of patients with HIV infection

Author(s): Sacchi P | Patruno SFA | Bruno R | Cima SMB | Previtali P | Franchini A | Nicolini L | Rognoni C | Sacchi L | Bellazzi R | Filice G
Volume: 2012
Issue: default
Year: 2012
Economic evaluation of intravenous iron treatments in the management of anemia patients in Greece

Author(s): Fragoulakis V | Kourlaba G | Goumenos D | Konstantoulakis M | Maniadakis N
Volume: 2012
Issue: default
Year: 2012
Evaluating the cost utility of racecadotril for the treatment of acute watery diarrhea in children: the RAWD model

Author(s): Rautenberg TA | Zerwes U | Foerster D | Aultman R
Volume: 2012
Issue: default
Year: 2012
Costs and clinical consequences of suboptimal atrial fibrillation management

Author(s): Singh SN
Volume: 2012
Issue: default
Year: 2012
Retrospective drug utilization review: impact of pharmacist interventions on physician prescribing

Author(s): Angalakuditi M | Gomes J
Volume: 2011
Issue: default
Year: 2011
The role of galenic innovation in improving treatment compliance and persistence: three case studies

Author(s): Zoellner Y | Balp MM | Gili Marco A
Volume: 2011
Issue: default
Year: 2011
Role of centralized review processes for making reimbursement decisions on new health technologies in Europe

Author(s): Stafinski T | Menon D | Davis C | McCabe C
Volume: 2011
Issue: default
Year: 2011
Corrigendum

Author(s): Zoellner Y | Balp MM | Gili Marco A
Volume: 2011
Issue: default
Year: 2011
Impact of early intervention and disease modification in patients with predementia Alzheimer’s disease: a Markov model simulation

Author(s): Budd D | Burns LC | Guo Z | L’Italien G | Lapuerta P
Volume: 2011
Issue: default
Year: 2011
Cost-effectiveness analysis of initial HIV treatment under Italian guidelines

Author(s): Colombo GL | Colangeli V | Di Biagio A | Di Matteo S | Viscoli C | Viale P
Volume: 2011
Issue: default
Year: 2011
Cost-effectiveness study of oral hypoglycemic agents in the treatment of outpatients with type 2 diabetes attending a public primary care clinic in Mexico City

Author(s): Díaz de León-Castañeda C | Altagracia-Martínez M | Kravzov-Jinich J | Cárdenas-Elizalde MR | Moreno-Bonett C | Martínez-Núñez JM
Volume: 2012
Issue: default
Year: 2012
Cost considerations in the management of atrial fibrillation – impact of dronedarone

Author(s): Khaykin Y | Shamiss Y
Volume: 2012
Issue: default
Year: 2012
Treatment profiles and costs of patients with chronic pain in the population setting

Author(s): Sicras Mainar A | Navarro Artieda R | Villoria Morillo J | Esquivias Escobar A
Volume: 2012
Issue: default
Year: 2012
Cross-market cost-effectiveness analysis of erlotinib as first-line maintenance treatment for patients with stable non-small cell lung cancer

Author(s): Vergnenègre A | Ray JA | Chouaid C | Grossi F | Bischoff HG | Heigener DF | Walzer S
Volume: 2012
Issue: default
Year: 2012
Health status, hospitalizations, day procedures, and physician costs associated with body mass index (BMI) levels in Ontario, Canada

Author(s): Tarride JE | Haq M | Taylor VH | Sharma AM | Nakhai-Pour HR,  O'Reilly D | Xie F | Dolovich L | Goeree R
Volume: 2012
Issue: default
Year: 2012
Predictors of antipsychotic monotherapy with olanzapine during a 1-year naturalistic study of schizophrenia patients in Japan

Author(s): Ye W | Ascher-Svanum H | Flynn JA | Tanji Y | Takahashi M
Volume: 2012
Issue: default
Year: 2012
Cost-effectiveness of rosuvastatin in comparison with generic atorvastatin and simvastatin in a Swedish population at high risk of cardiovascular events

Author(s): Gandhi SK | Jensen MM | Fox KM | Smolen L | Olsson AG | Paulsson T
Volume: 2012
Issue: default
Year: 2012
Transferability of health technology assessments and economic evaluations: a systematic review of approaches for assessment and application

Author(s): Goeree R | He J | O'Reilly D | Tarride J-E | Xie F | Lim M | Burke N
Volume: 2011
Issue: default
Year: 2011
Cost-effectiveness of early responders versus early nonresponders to atypical antipsychotic therapy

Author(s): Peng X | Ascher-Svanum H | Faries DE | Stauffer VL | Kollack-Walker S | Kinon BJ | Kane JM
Volume: 2011
Issue: default
Year: 2011
Cost–utility analysis of prophylaxis versus treatment on demand in severe hemophilia A

Author(s): Giorgio L Colombo | Sergio Di Matteo | Maria Elisa Mancuso | et al
Volume: 2011
Issue: default
Year: 2011
Adherence to antihypertensive medications and health outcomes among newly treated hypertensive patients

Author(s): Luca Degli Esposti | Stefania Saragoni | Silvia Benemei | et al
Volume: 2011
Issue: default
Year: 2011
Biosimilar medicines and cost-effectiveness

Author(s): Steven Simoens
Volume: 2011
Issue: default
Year: 2011
A cost-effectiveness analysis of different therapies in patients with chronic hepatitis B in Italy

Author(s): Giorgio L Colombo | Giovanni B Gaeta | Mauro Viganò | et al
Volume: 2011
Issue: default
Year: 2011
Indirect treatment comparison of bevacizumab + interferon-α-2a vs tyrosine kinase inhibitors in first-line metastatic renal cell carcinoma therapy

Author(s): Gerald HJ Mickisch | Björn Schwander | Bernard Escudier | et al
Volume: 2011
Issue: default
Year: 2011
Economic considerations for bariatric surgery and morbid obesity

Author(s): Eldo E Frezza | Mitchell Wacthell | Bradley Ewing
Volume: 2009
Issue: default
Year: 2009
Assessing cost-effectiveness in the management of multiple sclerosis

Author(s): Ceri J Phillips | Ioan Humphreys
Volume: 2009
Issue: default
Year: 2009
A cost–utility analysis of etanercept for the treatment of moderate-to-severe psoriasis in Italy

Author(s): Giorgio L Colombo | Sergio Di Matteo | Ketty Peris | Maria Concetta Fargnoli | et al.
Volume: 2009
Issue: default
Year: 2009
Economic considerations in the treatment of invasive aspergillosis: a review of voriconazole pharmacoeconomic studies

Author(s): Kem P Krueger | A Christie Nelson
Volume: 2009
Issue: default
Year: 2009
Breast cancer quality of life evaluation in Mexican Women at La Raza Hospital, Mexico City: A preliminary approach

Author(s): Jacobo Alejandro Gómez-Rico | Marina Altagracia-Martínez | Jaime Kravzov-Jinich | Rosario Cárdenas-Elizalde | Juan Carlos Hinojosa-Cruz | Consuelo Rubio-Poo
Volume: 2009
Issue: default
Year: 2008
Antihypertensive therapy among newly treated patients: An analysis of adherence and cost of treatment over years

Author(s): Luca Degli Esposti | Stefania Saragoni | Paolo Batacchi | et al
Volume: 2010
Issue: default
Year: 2010
The significance of presenteeism for the value of lost production: the case of rheumatoid arthritis

Author(s): Rikke Søgaard | Jan Sørensen | Louise Linde | et al
Volume: 2010
Issue: default
Year: 2010
Cost effectiveness and quality of life considerations in the treatment of hepatitis C infection

Author(s): H Jafferbhoy | W Gashau | JF Dillon
Volume: 2010
Issue: default
Year: 2010
Impact of disability on different domains of health-related quality of life in the noninstitutionalized general population

Author(s): Javier Mar | Isabel Larrañaga | Arantzazu Arrospide | et al
Volume: 2010
Issue: default
Year: 2010
Clinical and economic considerations of antiobesity treatment: a review of orlistat

Author(s): Armineh Zohrabian
Volume: 2010
Issue: default
Year: 2010
Cost-effectiveness analysis of corticosteroid inhaler devices in primary care asthma management: A real world observational study

Author(s): Linda Kemp | John Haughney | Neil Barnes | et al
Volume: 2010
Issue: default
Year: 2010
On the decision rules of cost-effective treatment for patients with diabetic foot syndrome

Author(s): John E Goulionis | Athanassios Vozikis | VK Benos | et al
Volume: 2010
Issue: default
Year: 2010
Testing the generalizability of national reimbursement rates with respect to local setting: the costs of abdominal aortic aneurysm surgery in Denmark

Author(s): Søren Løvstad Christensen | Mette Kjoelby | Lars Ehlers
Volume: 2010
Issue: default
Year: 2010
Inpatient charges and mental illness: Findings from the Nationwide Inpatient Sample 1999–2007

Author(s): Jim E Banta | Ivorie Belk | Kedon Newton | et al
Volume: 2010
Issue: default
Year: 2010
Decline in hospitalization risk and health care cost after initiation of depot antipsychotics in the treatment of schizophrenia

Author(s): Xiaomei Peng | Haya Ascher-Svanum | Douglas Faries et al
Volume: 2011
Issue: default
Year: 2011
The cost-effectiveness of venous-converted acid-base and blood gas status in pulmonary medical departments

Author(s): Lars Oddershede | Sabrina Storgaard Petersen | Asgerd Krogh Kristensen | et al
Volume: 2011
Issue: default
Year: 2010
Clinical efficacy issues in the treatment of multiple sclerosis: update of natalizumab

Author(s): Francesco Patti | Angelo Pappalardo
Volume: 2009
Issue: default
Year: 2009
Smoking cessation: an economic analysis and review of varenicline

Author(s): Michele A Faulkner
Volume: 2009
Issue: default
Year: 2009
Evaluating the cost-effectiveness of tiotropium versus salmeterol in the treatment of chronic obstructive pulmonary disease

Author(s): Shalini Naik | Khalid M Kamal | Patricia A Keys | et al
Volume: 2010
Issue: default
Year: 2010
Rituximab in the treatment of B-cell non-Hodgkin lymphoma, focus on outcomes and comparative effectiveness

Author(s): Firas Badin | John Hayslip
Volume: 2010
Issue: default
Year: 2010
Pharmacoeconomic considerations in the treatment of breast cancer

Author(s): Athanasios Pallis | Vasiliki Tsiantou | Efi Simou | et al
Volume: 2010
Issue: default
Year: 2010
Cost effectiveness of cord blood versus bone marrow and peripheral blood stem cells

Author(s): Thomas Bart
Volume: 2010
Issue: default
Year: 2010
The economic burden of TNFα inhibitors and other biologic treatments in Norway

Author(s): Jan Norum | Wenche Koldingsnes | Torfinn Aanes | et al
Volume: 2011
Issue: default
Year: 2011
Adherence and persistence with branded antidepressants and generic SSRIs among managed care patients with major depressive disorder

Author(s): Xianchen Liu | Yi Chen | Douglas E Faries | et al
Volume: 2011
Issue: default
Year: 2011
The costs of hospitalization in patients with acute exacerbation of chronic obstructive pulmonary disease

Author(s): Sevket Ozkaya | Serhat Findik | Atilla Guven Atici
Volume: 2011
Issue: default
Year: 2011
Management strategies and cost effectiveness in the prevention of cervical cancer

Author(s): Smita R Prasad
Volume: 2009
Issue: default
Year: 2009
Use of electronic medical records in oncology outcomes research

Author(s): Gena Kanas | Libby Morimoto | Fionna Mowat | et al
Volume: 2010
Issue: default
Year: 2010
Why do you need a reservation system?      Affiliate Program